We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function.

Myoferlin and dysferlin are members of the ferlin family of membrane proteins. Recent studies have shown that mutation or genetic disruption of myoferlin or dysferlin promotes muscular dystrophy-related phenotypes in mice, which are the result of impaired plasma membrane integrity. However, no biological functions have been ascribed to myoferlin in non-muscle tissues. Herein, using a proteomic analysis of endothelial cell (EC) caveolae/lipid raft microdomains we identified myoferlin in these domains and show that myoferlin is highly expressed in ECs and vascular tissues. The loss of myoferlin results in lack of proliferation, migration, and nitric oxide (NO) release in response to vascular endothelial growth factor (VEGF). Western blotting and surface biotinylation experiments show that loss of myoferlin reduces the expression level and autophosphorylation of VEGF receptor-2 (VEGFR-2) in native ECs. In a reconstituted cell system, transfection of myoferlin increases VEGFR-2 membrane expression and autophosphorylation in response to VEGF. In vivo, VEGFR-2 levels and VEGF-induced permeability are impaired in myoferlin-deficient mice. Mechanistically, myoferlin forms a complex with dynamin-2 and VEGFR-2, which prevents CBL-dependent VEGFR-2 polyubiquitination and proteasomal degradation. These data are the first to report novel biological activities for myoferlin and reveal the role of membrane integrity to VEGF signaling.

Pubmed ID: 17702744 RIS Download

Mesh terms: Animals | Calcium-Binding Proteins | Capillary Permeability | Caveolae | Cell Line | Cell Movement | Cell Proliferation | Dynamin II | Endothelial Cells | Gene Deletion | Humans | Membrane Proteins | Mice | Mice, Knockout | Muscle Proteins | Muscular Dystrophy, Animal | Nitric Oxide | Organ Specificity | Phenotype | Phosphorylation | Proteasome Endopeptidase Complex | Protein Processing, Post-Translational | Proteomics | Proto-Oncogene Proteins c-cbl | Ubiquitin | Vascular Endothelial Growth Factor A | Vascular Endothelial Growth Factor Receptor-2

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: HL64793
  • Agency: NHLBI NIH HHS, Id: N01-HV-28186
  • Agency: NHLBI NIH HHS, Id: P01 HL 70295
  • Agency: NHLBI NIH HHS, Id: R01 HL 57665
  • Agency: NHLBI NIH HHS, Id: R01 HL61371

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.